Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

Microneedling combined with minoxidil is more effective and safe for hair growth in men with hair loss.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

The hormonal contraceptive combination effectively reduces androgen excess and improves PCOS symptoms like acne, hair loss, and menstrual issues.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

The combination therapy improved hair growth and thickness in people with androgenetic alopecia.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The new treatment improved hair growth and thickness in people with hair loss.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Topical minoxidil, intralesional steroids, and cryotherapy significantly improve alopecia areata.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Anti-androgens are not better than birth control pills for PCOS, but can help with excess hair if pills don't work.

5-ARI therapy may help prevent prostate cancer progression.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.